Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications

Obstetrics and Gynecology

Volumn 110, Issue 2 I, 2007, Pages 363-368

  Stonek, Felix ^b   Hafner, Erich ^b   Philipp, Karl ^b   Hefler, Lukas A ^b   Bentz, Eva Katrin ^b   Tempfer, Clemens B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; DNA POLYMORPHISM; FEMALE; FETUS DEATH; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; CAUCASIAN; GENETICS; NEWBORN; PREGNANCY; PROSPECTIVE STUDY;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548449918     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000270122.13198.6f     Document Type: Article

References (34)

1. Creasy RK, Resnik R, editors. Maternal-fetal medicine: principles and practice. 3rd ed. Philadelphia (PA): W. B. Saunders; 1994. p. 609-10.
2. Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57-65.
3. Habibzadeh N, Schorah CJ, Smithells RW. The effects of maternal folic acid and vitamin C nutrition in early pregnancy on reproductive performance in the guinea-pig. Br J Nutr 1986;55:23-35.
4. Achon M, Reyes L, Alonso-Aperte E, Ubeda N, Varela-Moreiras G. High dietary folate supplementation affects gestational development and dietary protein utilization in rats. J Nutr 1999;129:1204-8.
5. Matte JJ, Girard CL, Tremblay GF. Effect of long-term addition of folic acid on folate status, growth performance, puberty attainment, and reproductive capacity of gilts. J Anim Sci 1993;71:151-7.
6. Wouters M, Boers G, Blom H, Trijbels F, Thomas C, Borm G, et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5.
7. Pietrzik K, Prinz R, Reusch K, Bung P, Mallmann P, Chronides A. Folate status and pregnancy outcome. Ann N Y Acad Sci 1992;669:371-3.
8. Bennett M. Vitamin B12 deficiency, infertility, and recurrent fetal loss. J Reprod Med 2001;46:209-12.
9. Unfried G, Griesmacher A, Weismuller W, Nagele F, Huber JC, Tempfer CB. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol 2002;99:614-9.
10. Scholl TO, Johnson WG. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 2000;71 suppl:1295-303S.
11. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod 2000;15:954-60.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
13. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
14. van der Molen EF, Arends GE, Nelen WL, van der Put NJ, Heil SG, Eskes TK, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000;182:1258-63.
15. Valdez LL, Quintero A, Garcia E, Olivares N, Celis A, Rivas F et al. Thrombophilic polymorphisms in preterm delivery. Blood Cells Mol Dis 2004;33:51-6.
16. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79:963-7.
17. Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M, et al. Familial thrombophilia and the occurrence of fetal growth restriction Haematologica 2001;86:428-31.
18. Sutterlin M, Bussen S, Ruppert D, Steck T. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod 1997;12:2292-6.
19. Jaaskelainen E, Keski-Nisula L, Toivonen S, Romppanen EL, Helisalmi S, et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy 2006;25:73-80.
20. Goddard KA, Tromp G, Romero R, Olson JM, Lu Q, Xu Z, et al. Candidate-gene association study of mothers with preeclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered 2007;63:1-16.
21. Kaiser T, Brennecke SP, Moses EK. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for preeclampsia/ eclampsia in Australian women. Gynecol Obstet Invest 2000;50:100-2.
22. Pegoraro RJ, Chikosi A, Rom L, Roberts C, Moodley J. Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia. Acta Obstet Gynecol Scand 2004;83:449-54.
23. Perez-Mutul J, Gonzalez-Herrera L, Sosa-Cabrera T, Martinez-Olivares R. A mutation in the 5,10-methylenetetrahydrofolate reductase gene is not associated with preeclampsia in women of southeast Mexico. Arch Med Res 2004;35:231-4.
24. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
25. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet 1999;21 suppl:5-9.
26. Tempfer CB, Riener EK, Hefler LA, Huber JC, Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone replacement therapy. Fertil Steril 2004;82:132-7.
27. Hefler L, Jirecek S, Heim K, Grimm C, Antensteiner G, Zeillinger R, et al. Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study. J Soc Gynecol Investig 2004;11:42-4.
28. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-8.
29. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005;105:182-92.
30. Tempfer C, Schneeberger C, Riener EK, Hefler LA, Keck C. Polymorphisms for risk assessment of pregnancy-associated disorders: review of the literature and meta-analysis. Geburtsh Frauenheilk 2004;64:1080-9.
31. van der Molen EF, Arends GE, Nelen WL, van der Put NJ, Heil SG, Eskes TK, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000;182:1258-63.
32. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-29.
33. Elstein E, Huan C, Fitchett D, Cantarovitch M, Marpole D. C677T gene mutation in methylenetetrahydrofolate reductase as a risk factor for cardiac allograft vasculopathy. Transplant Proc. 1999;31:99.
34. Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002;347:19-25.